Literature DB >> 478599

Leukocyte migration inhibition activity of nonimmune acute inflammatory pleural exudate.

A M Sultan, C J Dunn, D A Willoughby.   

Abstract

Material with leuckocyte migration inhibition (LMI) activity has been demonstrated in various types of nonimmunologically induced acute pleural inflammatory exudates. This activity is present in inflammatory cell-free exudate and appears to involved the deposition of fibrin around the migrating leukocyte, resulting in "cell-trapping." This is supported by the fact that removal or inhibition of fibrin formation leads to loss of exudate LMI activity. Both fibrinogen and complement as well as vitamin K-dependent clotting factors appear to be required for LMI activity. The mechanism involved in the LMI reaction and its significance in nonimmune and cell-mediated immune inflammation are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478599     DOI: 10.1007/bf00914188

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  18 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

Review 2.  Blood coagulation and the inflammatory response.

Authors:  T S Zimmerman; J Fierer; H Rothberger
Journal:  Semin Hematol       Date:  1977-10       Impact factor: 3.851

3.  Further link between complement activation and blood coagulation.

Authors:  H Prydz; A C Allison; H U Schorlemmer
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

Review 4.  Guidelines for the management of anticoagulant therapy.

Authors:  V Gurewich
Journal:  Semin Thromb Hemost       Date:  1976-01       Impact factor: 4.180

Review 5.  Coagulation pathways: interrelationships and control mechanisms.

Authors:  B Bennett
Journal:  Semin Hematol       Date:  1977-07       Impact factor: 3.851

6.  Induction of fibrin thrombi by monocytes.

Authors:  W B Shelley; L Juhlin
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

7.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

8.  The leucocoyte disappearance reaction in non-immune acute inflammation.

Authors:  A M Sultan; C J Dunn; P C Mimms; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1978-12       Impact factor: 7.996

9.  Association of tissue factor activity with the surface of cultured cells.

Authors:  J R Maynard; C A Heckman; F A Pitlick; Y Nemerson
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

10.  Studies on delayed hypersensitivity pleural exudates in guinea-pigs. II. The interrelationship of monocytic and lymphocytic cells with respect to migration activity.

Authors:  S Yamamoto; C J Dunn; D A Willoughby
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

View more
  6 in total

1.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  The role of kallikrein in leukocyte migration inhibition.

Authors:  A M Sultan; C J Dunn; D A Willoughby
Journal:  Inflammation       Date:  1979-07       Impact factor: 4.092

3.  Studies on the ability of inflammatory exudate obtained from acute and chronic phases of the inflammatory process to promote leukocyte locomotion in vitro.

Authors:  A D Sedgwick; J C Edwards; D A Willoughby
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

Review 4.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

5.  Modulation of human polymorphonuclear leukocyte chemotaxis by leukocyte extracts, bacterial products, inflammatory exudates, and polyelectrolytes.

Authors:  I Ginsburg; P G Quie
Journal:  Inflammation       Date:  1980-09       Impact factor: 4.092

6.  Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5n-3 DPA production.

Authors:  Juan Lei; Yu Zhou; Huakan Zhao; Yu Chen; Guifang Yan; Lei Wu; Yanquan Xu; Jiangang Zhang; Xiao Zhang; Jingchun Wang; Dingshan Li; Yongsheng Li
Journal:  Theranostics       Date:  2021-02-20       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.